Despite the plethora of evidence showing a strong association between diabetic cardiomyopathy and impaired myocardial glucose oxidation, our study demonstrates that extinguishing glucose oxidation via cardiac-specific deletion of PDH is sufficient to produce a cardiomyopathy-like phenotype characterized via diastolic dysfunction and cardiac hypertrophy. The gene discussed is PDP1; the disease is cardiac hypertrophy.